Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
3SBio (沈阳三生制药) and Ascentage Pharma will...
MDRNA, Inc. and AstraZeneca Investment (China) announced...
Tigermed Consulting formed a China clinical CRO alliance...
The first SEED Life Sciences Business Plan Competition...
Sichuan Kelun Pharma will raise 5 billion RMB ($735...
Qiming Venture Partners announced a 250 million RMB...
China’s 12th Five Year Plan (2011-2015) for...
The BioBay Investor Forum selected BeiGene LLC and Suzhou...
Shanghai Pharma scheduled its upcoming $1.2 billion Hong...
Chongqing Zhifei Biological Products bid $93 million for...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
